Schizophrenia - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Schizophrenia > What Your Doctor is Reading About Schizophrenia > Review Articles

Review Articles

1. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.

Author: Altamura AC; Bobo WV; Meltzer HY;
Institution: Department of Psychiatry, University of Milan, Hospital Luigi Sacco, Via G.B. Grassi 74, 20157 Milan, Italy. c.altamura@hsacco.it
Journal: Int Clin Psychopharmacol. 2007 Sep;22(5):249-67.
Abstract URL: Click here to view abstract

2. Quetiapine: dose-response relationship in schizophrenia.

Author: Sparshatt A; Jones S; Taylor D;
Institution: Pharmacy Department, Maudsley Hospital, Denmark Hill, London, England.
Journal: CNS Drugs. 2008;22(1):49-68; discussion 69-72.
Abstract URL: Click here to view abstract

3. Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications.

Author: Elias AN; Hofflich H;
Institution: The University of California, Irvine Medical Center, Orange, CA 92868, USA. anelias@uci.edu
Journal: Am J Med. 2008 Feb;121(2):98-104.
Abstract URL: Click here to view abstract

4. Schizophrenia endophenotypes as treatment targets.

Author: Thaker GK;
Institution: University of Maryland School of Medicine, Maryland Psychiatric Research Center, Department of Psychiatry, PO Box 21247, Baltimore, MD 21228, USA. gthaker@mprc.umaryland.edu
Journal: Expert Opin Ther Targets. 2007 Sep;11(9):1189-206.
Abstract URL: Click here to view abstract

5. Paliperidone for schizophrenia.

Author: Dolder C; Nelson M; Deyo Z;
Institution: School of Pharmacy, Wingate University, Wingate, NC 28174, USA. cdolder@wingate.edu
Journal: Am J Health Syst Pharm. 2008 Mar 1;65(5):403-13.
Abstract URL: Click here to view abstract

6. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

Author: Heres S; Davis J; Maino K; Jetzinger E; Kissling W; Leucht S;
Institution: Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen am Klinikum rechts der Isar, Moehlstrasse 26, 81675 Munich, Germany. s.heres@lrz.tum.de
Journal: Am J Psychiatry. 2006 Feb;163(2):185-94.
Abstract URL: Click here to view abstract

7. Evidence-based psychotherapy for schizophrenia.

Author: Dickerson FB; Lehman AF;
Institution: Sheppard Pratt Health System, Baltimore, Maryland 21204, USA.
Journal: J Nerv Ment Dis. 2006 Jan;194(1):3-9.
Abstract URL: Click here to view abstract

8. Cognitive behavior therapy for schizophrenia.

Author: Turkington D; Kingdon D; Weiden PJ;
Institution: Department of Psychiatry, Royal Victoria Infirmary, Newcastle-upon-Tyne, Tyne and Wear NE4 4LP, UK. douglas.turkington@ncl.ac.uk
Journal: Am J Psychiatry. 2006 Mar;163(3):365-73.
Abstract URL: Click here to view abstract

9. Schizophrenia: a review.

Author: Schultz SH; North SW; Shields CG;
Institution: Family Medicine Residency Program, University of Rochester School of Medicine and Dentistry, Rochester, New York 14620, USA. stephen_schultz@urmc.rochester.edu
Journal: Am Fam Physician. 2007 Jun 15;75(12):1821-9.
Abstract URL: Click here to view abstract

10. Schizophrenia.

Author: Picchioni MM; Murray RM;
Institution: King's College London, Institute of Psychiatry, Division of Psychological Medicine, London SE5 8AF. m.picchioni@iop.kcl.ac.uk
Journal: BMJ. 2007 Jul 14;335(7610):91-5.

11. Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.

Author: Weiden PJ; Buckley PF;
Institution: Department of Psychiatry, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, USA. pjweiden@msn.com
Journal: J Clin Psychiatry. 2007;68 Suppl 6:14-23.
Abstract URL: Click here to view abstract

12. Arts therapies for people with schizophrenia: an emerging evidence base.

Author: Crawford MJ; Patterson S;
Institution: Department of Psychological Medicine, Imperial College London, Claybrook Centre, 37 Claybrook Road, London W6 8LN, UK.m.crawford@imperial.ac.uk
Journal: Evid Based Ment Health. 2007 Aug;10(3):69-70.

13. Heterogeneity of treatment effects in schizophrenia.

Author: Stroup TS;
Institution: Department of Psychiatry, University of North Carolina at Chapel Hill, 10301 Neuroscience Hospital, Chapel Hill, North Carolina 27599-7160, USA. scott_stroup@med.unc.edu
Journal: Am J Med. 2007 Apr;120(4 Suppl 1):S26-31.
Abstract URL: Click here to view abstract

14. Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum.

Author: Yaeger D; Smith HG; Altshuler LL;
Institution: Department of Psychiatry, VA Greater Los Angeles Healthcare System, West Los Angeles Healthcare Center, CA 90073, USA. Deborah.Yaeger@va.gov
Journal: Am J Psychiatry. 2006 Dec;163(12):2064-70.

15. Drama therapy for schizophrenia or schizophrenia-like illnesses.

Author: Ruddy RA; Dent-Brown K;
Institution: University of Leeds, Academic Unit of Psychiatry & Behavioural Sciences, 15 Hyde Terrace, Leeds, UK, LS2 9LT. R.A.Ruddy@leeds.ac.uk
Journal: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005378.
Abstract URL: Click here to view abstract

16. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.

Author: Barnett AH; Mackin P; Chaudhry I; Farooqi A; Gadsby R; Heald A; Hill J; Millar H; Peveler R; Rees A; Singh V; Taylor D; Vora J; Jones PB;
Institution: Birmingham Heartlands Hospital, Birmingham, UK. anthony.barnett@heartofengland.nhs.uk
Journal: J Psychopharmacol. 2007 Jun;21(4):357-73.
Abstract URL: Click here to view abstract